⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 38 in last 7 days 🍎 Food: 116 in last 7 days 🧸 Products: 98 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 3 hours ago ⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 38 in last 7 days 🍎 Food: 116 in last 7 days 🧸 Products: 98 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 3 hours ago
🛡️ EUSW
🇬🇧
🧸 Product GR June 5, 2026

ACQUA DI CIQ EAU DE PARFUM

Eau de parfum, natural spray vaporisateur, 25 ml.

📷 Safety Gate / European Commission · Source
ACQUA DI CIQ EAU DE PARFUM
📷 Safety Gate / European Commission · Source
Risk level
Serious risk
Type
Chemical
Category
Cosmetics
Hazard
According to the list of ingredients, the product contains 2-(4-tert-butylbenzyl) propionaldehyde (BMHCA), which is prohibited in cosmetic products. BMHCA may harm the reproductive system, may harm the health of the unborn child and may cause skin sensitisation.
Origin
Greece

⚖️ Actions ordered by authorities

  • (to: Distributor) Withdrawal of the product from market
Barcode (GTIN): 6932762127999
🚨
Recall in effect
A consumer product has been flagged as dangerous in GR.
📈 Timeline
5 days active so far
June 6, 2026 June 10, 2026

What is this? This is a perfume spray called ACQUA DI CIQ EAU DE PARFUM. It has a chemical that should not be in cosmetics.

What's happening? The perfume contains a banned ingredient called BMHCA. This can harm unborn babies, the reproductive system, and may irritate skin.

Does this affect me? Anyone using this perfume in Greece may be at risk. Pregnant women and people with sensitive skin should be especially careful.

What should I do? Stop using this perfume right away. Ask your pharmacist or doctor if you have any health concerns.

🤖 This plain-language summary is automatically generated from the official agency notice using AI. It is for general information only — not medical advice. For decisions about your health, always consult a pharmacist or doctor and read the official source linked below.

🔬 Medical / technical details (for professionals)
Agency-published detail

Risk level: Serious risk · Type: Chemical · Category: Cosmetics · Hazard: According to the list of ingredients, the product contains 2-(4-tert-butylbenzyl) propionaldehyde (BMHCA), which is prohibited in cosmetic products. BMHCA may harm the reproductive system, may harm the health of the unborn child and may cause skin sensitisation. · Origin: Greece

First published
June 5, 2026
Last refreshed by us
1 hour ago
Severity (as classified)
Low
Official source
https://ec.europa.eu/safety-gate-alerts/screen/webReport/alertDetail/10099072

All information on this page comes from the official agency notice. We translate and summarise it; we don't add or edit facts.

Related alerts

❓ Frequently asked questions

What is this product recall alert about?
ACQUA DI CIQ EAU DE PARFUM. Risk level: Serious risk · Type: Chemical · Category: Cosmetics · Hazard: According to the list of ingredients, the product contains 2-(4-tert-butylbenzyl) propionaldehyde (BMHCA), which is prohibited in cosmetic products. BMHCA may harm the reproductive system, may harm the heal...
When was this alert issued?
This alert was issued on June 5, 2026 by EU Safety Gate.
Which countries are affected?
The alert applies to Greece.
How serious is this alert?
Low risk. A low risk means harm is unlikely under normal use. The alert is informational but still worth reading.
What should I do?
If you have this product at home, stop using it and return it to the point of purchase for a refund. Keep the receipt if you have one — most retailers refund without it for safety recalls.
Where can I find the official notice?
The full official notice is published on ec.europa.eu.

💬 Discussion

Share your experience or ask a question. Real names and email are optional but moderation friendly.

No comments yet — be the first.

We email a confirmation link. Your address stays private.

⚠️ We aggregate official notices. We do not give medical advice. For medical or legal decisions, consult the source agency and a qualified professional.